Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats

Background The present study was designed to evaluate serum lipid profile and tumor necrosis factor-alpha (TNF-ɑ) level in diabetic rats at implantation time. Type 2 diabetes mellitus (T2DM) could affect various systems, including innate immune system and it causes chronic low-grade inflammation, in...

Full description

Bibliographic Details
Main Authors: Abbas Bakhteyari, Parvaneh Nikpour, Fatemah Sadat Mostafavi, Nahid Eskandari, Mohammad Matinfar, Sara Soleimani Asl, Roshanak Aboutorabi
Format: Article
Language:English
Published: Royan Institute (ACECR), Tehran 2019-07-01
Series:International Journal of Fertility and Sterility
Subjects:
Online Access:http://www.ijfs.ir/article_45540_1cd34349c0ba8a4d26e56eecb65ff422.pdf
_version_ 1818403624175271936
author Abbas Bakhteyari
Parvaneh Nikpour
Fatemah Sadat Mostafavi
Nahid Eskandari
Mohammad Matinfar
Sara Soleimani Asl
Roshanak Aboutorabi
author_facet Abbas Bakhteyari
Parvaneh Nikpour
Fatemah Sadat Mostafavi
Nahid Eskandari
Mohammad Matinfar
Sara Soleimani Asl
Roshanak Aboutorabi
author_sort Abbas Bakhteyari
collection DOAJ
description Background The present study was designed to evaluate serum lipid profile and tumor necrosis factor-alpha (TNF-ɑ) level in diabetic rats at implantation time. Type 2 diabetes mellitus (T2DM) could affect various systems, including innate immune system and it causes chronic low-grade inflammation, increasing level of TNF-ɑ. Furthermore, T2DM is often accompanied by impaired lipid profile. Metformin and pioglitazone are used as the first and second lines of treatment for T2DM. Materials and Methods In this experimental study, 35 adult virgin female wistar rats, weighting 175-225 g, were randomly categorized into five groups: i. Control, ii. Sham, iii. Nicotinamide (NA)+streptozotocin (STZ) induced T2DM, iv. Diabetic+pioglitazone (20 mg/kg/day for 28 days oral administration), and v. Diabetic+metformin (100 mg/kg/day for 28 days oral administration). At the time of implantation, TNF-ɑ level in serum of rats was measured by ELISA kit. Glucose was measured using photometric method and lipid profiles were calculated by enzymatic methods. Results Level of TNF-ɑ in the diabetic group was significantly higher than other groups (P < 0.001). In metformin treated group, TNF-ɑ serum level was also significantly higher than pioglitazone treated group (P < 0.001). Fasting blood sugar (FBS) and lipid profiles were significantly higher in diabetic group. Conclusion Metformin and pioglitazone have similar effects on glucose, lipid profiles and TNF-ɑ serum levels. Among these drugs, pioglitazone has more efficient influence on TNF-α serum level, in comparison with metformin.
first_indexed 2024-12-14T08:27:13Z
format Article
id doaj.art-b96b1ee803b8463d9af2d4abbcf6a498
institution Directory Open Access Journal
issn 2008-076X
2008-0778
language English
last_indexed 2024-12-14T08:27:13Z
publishDate 2019-07-01
publisher Royan Institute (ACECR), Tehran
record_format Article
series International Journal of Fertility and Sterility
spelling doaj.art-b96b1ee803b8463d9af2d4abbcf6a4982022-12-21T23:09:37ZengRoyan Institute (ACECR), TehranInternational Journal of Fertility and Sterility2008-076X2008-07782019-07-0113214815310.22074/ijfs.2019.563645540Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic RatsAbbas Bakhteyari0Parvaneh Nikpour1Fatemah Sadat Mostafavi2Nahid Eskandari3Mohammad Matinfar4Sara Soleimani Asl5Roshanak Aboutorabi6Department of Anatomical Sciences, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IranDepartment of Genetics and Molecular Biology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran;Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicablDepartment of Anatomical Sciences, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran4Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran5Department of Internal Medicine Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran6Endometrium and Endometriosis Research Center, Hamedan University of Medical Sciences, Hamedan, IranDepartment of Anatomical Sciences, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IranBackground The present study was designed to evaluate serum lipid profile and tumor necrosis factor-alpha (TNF-ɑ) level in diabetic rats at implantation time. Type 2 diabetes mellitus (T2DM) could affect various systems, including innate immune system and it causes chronic low-grade inflammation, increasing level of TNF-ɑ. Furthermore, T2DM is often accompanied by impaired lipid profile. Metformin and pioglitazone are used as the first and second lines of treatment for T2DM. Materials and Methods In this experimental study, 35 adult virgin female wistar rats, weighting 175-225 g, were randomly categorized into five groups: i. Control, ii. Sham, iii. Nicotinamide (NA)+streptozotocin (STZ) induced T2DM, iv. Diabetic+pioglitazone (20 mg/kg/day for 28 days oral administration), and v. Diabetic+metformin (100 mg/kg/day for 28 days oral administration). At the time of implantation, TNF-ɑ level in serum of rats was measured by ELISA kit. Glucose was measured using photometric method and lipid profiles were calculated by enzymatic methods. Results Level of TNF-ɑ in the diabetic group was significantly higher than other groups (P < 0.001). In metformin treated group, TNF-ɑ serum level was also significantly higher than pioglitazone treated group (P < 0.001). Fasting blood sugar (FBS) and lipid profiles were significantly higher in diabetic group. Conclusion Metformin and pioglitazone have similar effects on glucose, lipid profiles and TNF-ɑ serum levels. Among these drugs, pioglitazone has more efficient influence on TNF-α serum level, in comparison with metformin.http://www.ijfs.ir/article_45540_1cd34349c0ba8a4d26e56eecb65ff422.pdfdiabetes mellitusembryo implantationmetforminpioglitazonetumor necrosis factoralpha
spellingShingle Abbas Bakhteyari
Parvaneh Nikpour
Fatemah Sadat Mostafavi
Nahid Eskandari
Mohammad Matinfar
Sara Soleimani Asl
Roshanak Aboutorabi
Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats
International Journal of Fertility and Sterility
diabetes mellitus
embryo implantation
metformin
pioglitazone
tumor necrosis factor
alpha
title Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats
title_full Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats
title_fullStr Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats
title_full_unstemmed Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats
title_short Impact of Metformin and Pioglitazone on Serum Level of Tumor Necrosis Factor-Alpha and Lipid Profiles during Implantation Window in Diabetic Rats
title_sort impact of metformin and pioglitazone on serum level of tumor necrosis factor alpha and lipid profiles during implantation window in diabetic rats
topic diabetes mellitus
embryo implantation
metformin
pioglitazone
tumor necrosis factor
alpha
url http://www.ijfs.ir/article_45540_1cd34349c0ba8a4d26e56eecb65ff422.pdf
work_keys_str_mv AT abbasbakhteyari impactofmetforminandpioglitazoneonserumleveloftumornecrosisfactoralphaandlipidprofilesduringimplantationwindowindiabeticrats
AT parvanehnikpour impactofmetforminandpioglitazoneonserumleveloftumornecrosisfactoralphaandlipidprofilesduringimplantationwindowindiabeticrats
AT fatemahsadatmostafavi impactofmetforminandpioglitazoneonserumleveloftumornecrosisfactoralphaandlipidprofilesduringimplantationwindowindiabeticrats
AT nahideskandari impactofmetforminandpioglitazoneonserumleveloftumornecrosisfactoralphaandlipidprofilesduringimplantationwindowindiabeticrats
AT mohammadmatinfar impactofmetforminandpioglitazoneonserumleveloftumornecrosisfactoralphaandlipidprofilesduringimplantationwindowindiabeticrats
AT sarasoleimaniasl impactofmetforminandpioglitazoneonserumleveloftumornecrosisfactoralphaandlipidprofilesduringimplantationwindowindiabeticrats
AT roshanakaboutorabi impactofmetforminandpioglitazoneonserumleveloftumornecrosisfactoralphaandlipidprofilesduringimplantationwindowindiabeticrats